Mochida Pharmaceutical Co., Ltd.implemented “MOIRe”, an open innovation programme for drug discovery based on proposals from academic researchers since 2019. The company welcomes applications from researchers with a great interest in connecting drug discovery seeds to pharmaceutical development.
Applicants would be researchers and research representatives affiliated with public research institutions, universities, university-originated venture companies, etc…
The company has three main interest research disease areas: women’s health, for instance, endometriosis, uterine fibroid, pre-eclampsia, or other diseases with a high unmet medical need in obstetrics and gynaecology; and digestive diseases such as inflammatory bowel disease, NSAIDs-induced bowel injury or other digestive diseases with a high unmet medical need. Moreover, the third area is researching intractable & rare diseases.
Application period: 1 June 2021, to 31 July 2021
Research period: One year in principle
Research expenses: Maximum US$ 50,000 / project
The amount is decided for each project after consultation.
Application form and more detail information available online.